PBF-1350

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePBF-1350
Drug Alias NamePBF-1350
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor antagonistsAdenosine A2b receptor antagonists
TargetsAdenosine A2b receptorAdenosine A2a receptor
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPalobiofarma Sl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPalobiofarma Sl
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A